MX2020013778A - Composiciones, sistemas y metodos de amplificacion basados en crispr/cas y transposasa. - Google Patents
Composiciones, sistemas y metodos de amplificacion basados en crispr/cas y transposasa.Info
- Publication number
- MX2020013778A MX2020013778A MX2020013778A MX2020013778A MX2020013778A MX 2020013778 A MX2020013778 A MX 2020013778A MX 2020013778 A MX2020013778 A MX 2020013778A MX 2020013778 A MX2020013778 A MX 2020013778A MX 2020013778 A MX2020013778 A MX 2020013778A
- Authority
- MX
- Mexico
- Prior art keywords
- target nucleic
- nucleic acid
- systems
- methods
- crispr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/125—Specific component of sample, medium or buffer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/13—Plant traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690160P | 2018-06-26 | 2018-06-26 | |
| US201862767077P | 2018-11-14 | 2018-11-14 | |
| PCT/US2019/039195 WO2020006049A1 (en) | 2018-06-26 | 2019-06-26 | Crispr/cas and transposase based amplification compositions, systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020013778A true MX2020013778A (es) | 2021-05-27 |
Family
ID=67263112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020013778A MX2020013778A (es) | 2018-06-26 | 2019-06-26 | Composiciones, sistemas y metodos de amplificacion basados en crispr/cas y transposasa. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12559786B2 (enExample) |
| EP (1) | EP3814519A1 (enExample) |
| JP (1) | JP2021528975A (enExample) |
| KR (1) | KR20210024009A (enExample) |
| CN (1) | CN112368396A (enExample) |
| AU (1) | AU2019294690A1 (enExample) |
| BR (1) | BR112020025319A2 (enExample) |
| CA (1) | CA3101066A1 (enExample) |
| MX (1) | MX2020013778A (enExample) |
| SG (1) | SG11202011240YA (enExample) |
| WO (1) | WO2020006049A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019010422A1 (en) | 2017-07-07 | 2019-01-10 | The Broad Institute, Inc. | ANTIVIRAL THERAPY BASED ON THE CRISPR SYSTEM |
| US12171783B2 (en) | 2017-11-13 | 2024-12-24 | The Broad Institute, Inc. | Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas |
| SG11202011240YA (en) | 2018-06-26 | 2020-12-30 | Broad Inst Inc | Crispr/cas and transposase based amplification compositions, systems and methods |
| US12402610B2 (en) | 2018-11-09 | 2025-09-02 | The Broad Institute, Inc. | Methods and compositions for modulating innate lymphoid cell pathogenic effectors |
| WO2021046243A2 (en) | 2019-09-03 | 2021-03-11 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| US20230340537A1 (en) | 2020-01-17 | 2023-10-26 | The Broad Institute, Inc. | Small type ii-d cas proteins and methods of use thereof |
| EP4291678A1 (en) * | 2021-02-09 | 2023-12-20 | Sherlock Biosciences, Inc. | Nucleic acid amplification using promoter primers |
| WO2022241029A1 (en) | 2021-05-11 | 2022-11-17 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| WO2023283622A1 (en) | 2021-07-08 | 2023-01-12 | Montana State University | Crispr-based programmable rna editing |
| US11814689B2 (en) | 2021-07-21 | 2023-11-14 | Montana State University | Nucleic acid detection using type III CRISPR complex |
| KR102576803B1 (ko) * | 2022-10-14 | 2023-09-12 | 주식회사 풀무원 | CRISPR-Cas 기반의 리스테리아 모노사이토제네스 검출용 조성물 및 이를 이용한 리스테리아 모노사이토제네스 검출방법 |
| US12435357B2 (en) | 2022-12-22 | 2025-10-07 | Kanso Diagnostics Ltd. | Diagnostic device for detecting a target nucleic acid molecule in a biological sample |
| WO2024238563A2 (en) * | 2023-05-15 | 2024-11-21 | Vedabio, Inc. | Arrayed detection of target molecules via crispr cascade reactions |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005038029A2 (en) | 2003-10-10 | 2005-04-28 | Promega Corporation | Luciferase biosensor |
| US9193959B2 (en) | 2010-04-16 | 2015-11-24 | Roche Diagnostics Operations, Inc. | T7 RNA polymerase variants with enhanced thermostability |
| CN116622704A (zh) | 2012-07-25 | 2023-08-22 | 布罗德研究所有限公司 | 可诱导的dna结合蛋白和基因组干扰工具及其应用 |
| MX380562B (es) | 2012-12-12 | 2025-03-12 | Broad Inst Inc | Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias. |
| WO2014093709A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| EP2931899A1 (en) | 2012-12-12 | 2015-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| SG10201707569YA (en) | 2012-12-12 | 2017-10-30 | Broad Inst Inc | Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications |
| EP3064585B1 (en) | 2012-12-12 | 2020-02-05 | The Broad Institute, Inc. | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| CN105209621B (zh) | 2012-12-12 | 2021-05-25 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| KR102955556B1 (ko) | 2012-12-12 | 2026-04-22 | 더 브로드 인스티튜트, 인코퍼레이티드 | 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물 |
| PT2931898E (pt) | 2012-12-12 | 2016-06-16 | Harvard College | Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais |
| US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
| ES2777217T3 (es) | 2013-06-17 | 2020-08-04 | Broad Inst Inc | Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias |
| EP3011033B1 (en) | 2013-06-17 | 2020-02-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof |
| SG11201510327TA (en) | 2013-06-17 | 2016-01-28 | Broad Inst Inc | Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells |
| KR20250012194A (ko) | 2013-06-17 | 2025-01-23 | 더 브로드 인스티튜트, 인코퍼레이티드 | 바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용 |
| WO2014204725A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation |
| WO2014204723A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions |
| JP6738728B2 (ja) | 2013-06-17 | 2020-08-19 | ザ・ブロード・インスティテュート・インコーポレイテッド | 肝臓ターゲティングおよび治療のためのＣＲＩＳＰＲ−Ｃａｓ系、ベクターおよび組成物の送達および使用 |
| EP3058091B1 (en) | 2013-10-18 | 2020-03-25 | The Broad Institute, Inc. | Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing |
| CN111218447B (zh) | 2013-11-07 | 2024-10-11 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| CN105899658B (zh) | 2013-12-12 | 2020-02-18 | 布罗德研究所有限公司 | 针对hbv和病毒性疾病以及障碍的crispr-cas系统和组合物的递送、用途和治疗应用 |
| WO2015089419A2 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| CA2932439A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute, Inc. | Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes |
| WO2015089364A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crystal structure of a crispr-cas system, and uses thereof |
| KR20160097338A (ko) | 2013-12-12 | 2016-08-17 | 더 브로드 인스티튜트, 인코퍼레이티드 | 뉴클레오티드 반복 장애에서의 ｃｒｉｓｐｒ-ｃａｓ 시스템의 조성물 및 방법 및 용도 |
| JP6793547B2 (ja) | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| WO2015089473A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
| CN111206032B (zh) | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
| CN105463066B (zh) * | 2014-09-04 | 2019-05-17 | 中国科学院北京基因组研究所 | 一种dna扩增方法 |
| EP3985115A1 (en) | 2014-12-12 | 2022-04-20 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
| EP3230452B1 (en) | 2014-12-12 | 2025-06-11 | The Broad Institute, Inc. | Dead guides for crispr transcription factors |
| WO2016094874A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Escorted and functionalized guides for crispr-cas systems |
| PT3234187T (pt) * | 2014-12-15 | 2021-05-26 | Illumina Inc | Método para colocação de moleculas de alvo unico num substrato |
| WO2016106244A1 (en) | 2014-12-24 | 2016-06-30 | The Broad Institute Inc. | Crispr having or associated with destabilization domains |
| WO2016138292A1 (en) * | 2015-02-25 | 2016-09-01 | Igenomx International Genomics Corporation | Methods and compositions for in silico long read sequencing |
| US11155822B2 (en) * | 2015-05-14 | 2021-10-26 | Universidad De Los Andes | Transposon that promotes functional DNA expression in episomal DNAs and method to enhance DNA transcription during functional analysis of metagenomic libraries |
| US10894980B2 (en) * | 2015-07-17 | 2021-01-19 | President And Fellows Of Harvard College | Methods of amplifying nucleic acid sequences mediated by transposase/transposon DNA complexes |
| EP3445853A1 (en) * | 2016-04-19 | 2019-02-27 | The Broad Institute, Inc. | Cpf1 complexes with reduced indel activity |
| CA3026110A1 (en) | 2016-04-19 | 2017-11-02 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| CN105861552B (zh) | 2016-04-25 | 2019-10-11 | 西北农林科技大学 | 一种T7 RNA聚合酶介导的CRISPR/Cas9基因编辑系统的构建方法 |
| CN105950639A (zh) * | 2016-05-04 | 2016-09-21 | 广州美格生物科技有限公司 | 金黄色葡萄球菌CRISPR/Cas9系统的制备及其在构建小鼠模型中的应用 |
| AU2017283713B2 (en) | 2016-06-17 | 2021-04-08 | Massachusetts Institute Of Technology | Type VI CRISPR orthologs and systems |
| KR102993694B1 (ko) * | 2016-12-09 | 2026-07-22 | 더 브로드 인스티튜트, 인코퍼레이티드 | Crispr 이펙터 시스템 기반 진단 |
| CN111108220B (zh) | 2017-03-15 | 2024-11-19 | 博德研究所 | 用于病毒检测的基于crispr效应系统的诊断 |
| US10844372B2 (en) * | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| CN107937328B (zh) * | 2017-11-30 | 2018-09-14 | 中央民族大学 | 基于细胞的比较器及应用与细胞计算机 |
| SG11202011240YA (en) | 2018-06-26 | 2020-12-30 | Broad Inst Inc | Crispr/cas and transposase based amplification compositions, systems and methods |
-
2019
- 2019-06-26 SG SG11202011240YA patent/SG11202011240YA/en unknown
- 2019-06-26 CA CA3101066A patent/CA3101066A1/en active Pending
- 2019-06-26 MX MX2020013778A patent/MX2020013778A/es unknown
- 2019-06-26 EP EP19739830.8A patent/EP3814519A1/en not_active Withdrawn
- 2019-06-26 JP JP2020572532A patent/JP2021528975A/ja active Pending
- 2019-06-26 WO PCT/US2019/039195 patent/WO2020006049A1/en not_active Ceased
- 2019-06-26 KR KR1020217001470A patent/KR20210024009A/ko not_active Withdrawn
- 2019-06-26 US US17/054,428 patent/US12559786B2/en active Active
- 2019-06-26 AU AU2019294690A patent/AU2019294690A1/en not_active Abandoned
- 2019-06-26 BR BR112020025319-7A patent/BR112020025319A2/pt not_active IP Right Cessation
- 2019-06-26 CN CN201980043102.2A patent/CN112368396A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210024009A (ko) | 2021-03-04 |
| AU2019294690A1 (en) | 2020-12-03 |
| EP3814519A1 (en) | 2021-05-05 |
| WO2020006049A1 (en) | 2020-01-02 |
| US12559786B2 (en) | 2026-02-24 |
| CN112368396A (zh) | 2021-02-12 |
| JP2021528975A (ja) | 2021-10-28 |
| SG11202011240YA (en) | 2020-12-30 |
| US20210147915A1 (en) | 2021-05-20 |
| CA3101066A1 (en) | 2020-01-02 |
| BR112020025319A2 (pt) | 2021-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020013836A (es) | Métodos, sistemas y diagnósticos de amplificación basados en el sistema efector crispr. | |
| MX2021007302A (es) | Metodos y composiciones para la deteccion de productos de amplificacion. | |
| MX2020000481A (es) | Uso de proteína cas, método para detectar moléculas de ácido nucleico objetivo y kit. | |
| CY1119346T1 (el) | Ισοθερμικη ενισχυση νουκλεικων οξεων | |
| MX2021000946A (es) | Metodo de deteccion de acido nucleico. | |
| EP4269611A3 (en) | Polynucleotide enrichment and amplification using argonaute systems | |
| EP4471156A3 (en) | Determining 5' transcript sequences | |
| NZ701145A (en) | Compositions and methods for quantifying a nucleic acid sequence in a sample | |
| AU2018234832A1 (en) | CRISPR effector system based diagnostics for virus detection | |
| WO2018135838A3 (ko) | Dna 단일가닥 절단에 의한 염기 교정 비표적 위치 확인 방법 | |
| WO2010115044A3 (en) | Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation | |
| MX2023008931A (es) | Complejos de transposoma ligados a superficie de complejo. | |
| HK1252166A1 (zh) | 从环状rna产生环状dna的方法 | |
| WO2013006793A3 (en) | Direct amplification and detection of viral and bacterial pathogens | |
| CO2019004124A2 (es) | Método y sistema para la preparación y secuenciación de biblioteca basada en crispr | |
| EP4644568A3 (en) | Methods for targeted nucleic acid library formation | |
| UA115082C2 (uk) | Спосіб детекції нуклеїновокислотної послідовності-мішені в аналізі із розщепленням та подовженням рто | |
| BR112016029907A2 (pt) | enriquecimento geneticamente adaptado e reação em cadeia da polimerase para a rápida detecção de microrganismos". | |
| SG11201903066RA (en) | Method for multiplex detection of methylated dna | |
| WO2020132316A3 (en) | Methods for nucleic acid target enrichment | |
| BR112021008427A8 (pt) | Mutagênese direcionada usando editores de bases | |
| EP3325665A4 (en) | AMPLIFICATION PROCEDURE FOR NUCLEIC ACID SEQUENCES | |
| EP4512527A3 (en) | Microfluidic siphoning array for nucleic acid quantification | |
| EP3880839A4 (en) | INTEGRATED MICROFLUIDIC SYSTEM FOR DROPLET PRODUCTION, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS | |
| DE602008006254D1 (de) | Doppel-oligonukleotid-nukleinsäurenachweisverfahren |